Literature DB >> 27940184

SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.

Nadine Leber1, Leonard Kaps2, Misbah Aslam3, Jonathan Schupp4, Alexander Brose2, David Schäffel5, Karl Fischer6, Mustafa Diken7, Dennis Strand8, Kaloian Koynov5, Andrea Tuettenberg4, Lutz Nuhn9, Rudolf Zentel10, Detlef Schuppan11.   

Abstract

Cationic nanohydrogel particles have become an attractive tool for systemic siRNA delivery, but improvement of their in vivo tolerance is desirable, especially to prevent potential long term side effects by tissue and cellular accumulation. Here, we designed novel ketal cross-linked cationic nanohydrogel particles that were assessed for reduced tissue accumulation and robust siRNA delivery in vitro and in vivo. An oligo-amine cross-linker equipped with a ketal moiety in its core was synthesized and applied to nanohydrogel cross-linking of self-assembled reactive ester block copolymers in DMSO. The resulting acid-sensitive cationic nanoparticles spontaneously disassembled over time in acidic milieu, as investigated by dynamic light scattering. Fluorescent correlation spectroscopy showed effective complexation with siRNA as well as its release upon particle degradation at endosomal pH. These properties resulted in an enhanced in vitro gene knockdown for the acid-degradable cationic nanoparticles compared to their non-degradable spermine analogues. In a murine liver fibrosis model enhanced carrier and payload accumulation in the fibrotic tissue facilitated sequence-specific gene knockdown and prevented fibrosis progression. Long-term monitoring of the carrier in the body showed an enhanced clearance for the acid-degradable carrier, even after multiple dosing. Therefore, these acid-degradable cationic nanohydrogel particles can be considered as promising siRNA carriers for in vivo purposes towards therapeutic applications.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acid degradable; Cationic nanohydrogels; Fibrosis; Ketal cross-linker; siRNA

Mesh:

Substances:

Year:  2016        PMID: 27940184     DOI: 10.1016/j.jconrel.2016.12.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

2.  Control over Imidazoquinoline Immune Stimulation by pH-Degradable Poly(norbornene) Nanogels.

Authors:  Johannes Kockelmann; Judith Stickdorn; Sabah Kasmi; Jana De Vrieze; Michaela Pieszka; David Yuen W Ng; Sunil A David; Bruno G De Geest; Lutz Nuhn
Journal:  Biomacromolecules       Date:  2020-04-16       Impact factor: 6.988

3.  In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by α-Mannosyl-Functionalized Cationic Nanohydrogel Particles.

Authors:  Leonard Kaps; Nadine Leber; Adrian Klefenz; Niklas Choteschovsky; Rudolf Zentel; Lutz Nuhn; Detlef Schuppan
Journal:  Cells       Date:  2020-08-15       Impact factor: 6.600

Review 4.  Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology.

Authors:  Ernesto Bockamp; Sebastian Rosigkeit; Dominik Siegl; Detlef Schuppan
Journal:  Cells       Date:  2020-09-15       Impact factor: 6.600

5.  pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.

Authors:  Leonard Kaps; Anne Huppertsberg; Niklas Choteschovsky; Adrian Klefenz; Feyza Durak; Babara Schrörs; Mustafa Diken; Emma Eichler; Sebastian Rosigkeit; Sascha Schmitt; Christian Leps; Alicia Schulze; Friedrich Foerster; Ernesto Bockamp; Bruno G De Geest; Kaloian Koynov; Hans-Joachim Räder; Stefan Tenzer; Federico Marini; Detlef Schuppan; Lutz Nuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-15       Impact factor: 12.779

6.  Dual-responsive degradable core-shell nanogels with tuneable aggregation behaviour.

Authors:  Dominic M Gray; Adam R Town; Edyta Niezabitowska; Steve P Rannard; Tom O McDonald
Journal:  RSC Adv       Date:  2022-01-13       Impact factor: 3.361

Review 7.  The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.

Authors:  Maurice Michel; Leonard Kaps; Annett Maderer; Peter R Galle; Markus Moehler
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

8.  Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels.

Authors:  Maximilian Scherger; Evangelia Bolli; Ana Rita Pombo Antunes; Sana Arnouk; Judith Stickdorn; Alexandra Van Driessche; Hansjörg Schild; Stephan Grabbe; Bruno G De Geest; Jo A Van Ginderachter; Lutz Nuhn
Journal:  Cells       Date:  2020-10-01       Impact factor: 6.600

Review 9.  Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers.

Authors:  Leonard Kaps; Detlef Schuppan
Journal:  Cells       Date:  2020-09-03       Impact factor: 6.600

10.  Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators.

Authors:  Anne Huppertsberg; Leonard Kaps; Zifu Zhong; Sascha Schmitt; Judith Stickdorn; Kim Deswarte; Francis Combes; Christian Czysch; Jana De Vrieze; Sabah Kasmi; Niklas Choteschovsky; Adrian Klefenz; Carolina Medina-Montano; Pia Winterwerber; Chaojian Chen; Matthias Bros; Stefan Lienenklaus; Niek N Sanders; Kaloian Koynov; Detlef Schuppan; Bart N Lambrecht; Sunil A David; Bruno G De Geest; Lutz Nuhn
Journal:  J Am Chem Soc       Date:  2021-06-24       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.